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We have previously (1-3) shown that human T lymphocytes that have been primed 
to allogeneic stimulators in mixed lymphocyte culture (MLC), acquire the capacity 
not only of expressing HLA-D and DR antigens but also of stimulating autologous 
MLC  responses  (AMLR).  This observation has lead us to propose that  the Ia-like 
antigens expressed by primed T cells may be associated with idiotypes that trigger the 
anti-idiotype lymphocyte response,  and that  by analogy with  the antibody system, 
such anti-idiotypes may regulate the T cell immune response (3). 
Because previous studies, however, have shown that resting T lymphocytes respond 
in AMLR  to cells expressing HLA-D/DR  antigens,  such as B cells and monocytes 
(4-6), proof to the effect  that the autologous MLC reactivity to aUoactivated T  cells 
is truly idiotype-  (i.e.,  receptor-)  specific,  rather than specific for self-Ia,  is required. 
The present  experiments  demonstrate that  T  ceils  primed against autologous allo- 
stimulated T  lymphoblasts  (AAL)  display specific  "memory" responses against  the 
original  autostimulator  in  the  primed  lymphocyte  test  (PLT)  and  fail  to  exhibit 
secondary reactivity  to autologous T  lymphoblasts  (AL)  primed against  a  different 
HLA-D/DR specificity. 
Materials and Methods 
Lymphocyte Preparations.  Blood was obtained from healthy volunteers with a mean age of 32 
yr. Peripheral blood lymphocytes (PBL)  containing <5% granulocytes were isolated by Ficoll- 
Hypaque gradient centrifugation. The suspensions were depleted of monocytes by removal of 
cells adhering to petri dishes. T  cells were separated by the thrombin-nylon  wool method (7). 
Further purification ofT cells was accomplished by incubating 1 ×  107 lymphocytes with 1/~g 
of mouse monoclonal OKT-3 antibody (Ortho Pharmaceutical, Raritan, N  J), and subsequently 
rosetting the T  lymphocytes with sheep erythrocytes (SRBC) coated with purified anti-mouse 
IgG (8). After lysing the SRBC, T  cells were washed and resuspended in RPMI 1640 culture 
medium supplemented with glutamine, antibiotics, and pooled normal male serum. Immuno- 
fluorescence determination using a Spectrum III Cytofluorometer (Ortho Diagnostics) showed 
that >95% of the cells contained by these suspensions were OKT-3 positive. 
Priming of OKT-3-positive T  Cells against AAL.  OKT-3  + T  cells obtained from  fresh  PBL 
were used as responders (1 ×  107 cells in 10 ml of medium) and were primed in 9-d MLC with 
an equal number of irradiated AAL, representing the stimulating cells. AAL were obtained 
from a 5-d MLC between the same responder and irradiated monocyte-depleted lymphocytes 
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from  a  HLA-DR-half-identical  allostimulator.  Lymphoblasts  were  obtained  from  the  5-d 
culture by differential centrifugation on a 55% isotonic Percoll suspension (1.072 g/ml), followed 
by  centrifugation  through  a  30%  Percoll  suspension  for  removal  of dead  cell  debris  (9). 
Cytofluorometric  examination  of AAL  showed  that  virtually  all  cells  were  OKT-3  +,  Ia  ÷ 
lymphoblasts that  displayed  no surface  human  Ig.  The  HLA-DR  phenotype of AAL was 
indistinguishable  from that expressed  by fresh B lymphocytes from the same responder.  For 
restimulation experiments, anti-AAL PLT were plated  at  a concentration of 5 X  104 cells/ 
culture  and  challenged  in  triplicate  reactions  with  an  equal  number of stimulating  cells. 
Cultures were labeled with tritiated thymidine after 48 h of incubation and processed for liquid 
scintillation counting 18 h later (1-3). 
Results 
The  aim of these experiments  was  to determine  whether  T  lymphocytes primed 
against AAL display specific immunological memory to the original stimulator, and 
whether  this  response  is  inhibited  by  the  mouse  monoclonal  antibody  (MAb)  to 
human Ia-like antigens, MAb Q5/13  (10). An example of the results obtained is given 
in Table I. Purified T  lymphocytes from individual A, whose phenotype is DR3,DR5, 
were primed against AL, which  had been alloactivated in a  5-d MLC with a  DR2, 
DR5 stimulator  (individual  B).  This PLT, primed to "autologous anti-DR2 blasts," 
was rechallenged with the following irradiated stimulators:  (a) autologous anti-DR2 
blasts  derived  from  the  same  responder-stimulator  combination  (ABx)  and  from 
another MLC  (AEx)  in which  the DR3,DR5  responder was primed against  a  DR2 
homozygote (individual  E);  (b)  autologous anti-DR4  blasts  (derived  from an MLC 
[ACx]  with  individual  C,  a  DR3,DR4  stimulator);  (c)  autologous  anti-DR1  blasts 
(derived from an MLC  (ADx)  with individual  D, a  DR1,DR3  stimulator);  and  (d) 
monocyte-depleted lymphocytes from each allostimulator  (B,  C, D, and  E)  used for 
priming the AL. These stimulators were also used for challenging a 9-d PLT raised by 
priming PBL from individual B against lymphoblasts derived from an A-anti-B MLC. 
Parallel cultures were tested under the same conditions, yet 20 ~l of MAb Q5/13 were 
added to each reaction at the time when the stimulators were plated. 
T  lymphocytes primed to autologous anti-DR2  blasts displayed secondary, accel- 
erated  responses only when  rechallenged  with  AL activated against  DR2  in  MLC 
with the original DR2, DR5 stimulator (individual B) or in MLC with a  DR2, DR2 
homozygous donor (individual E). In contrast, AL primed against DR4 or DR1 failed 
to induce a  secondary MLC response. Such anti-self-primed lympbocytes also failed 
to  display  an  accelerated  (66  h)  response  when  challenged  with  autologous  or 
allogeneic  PBL.  The  monoclonal  anti-Ia had  no effect on  the  magnitude  of these 
reactions. Fresh (resting) OKT-3  + lymphocytes from the same responder (A) displayed 
little,  if any, reactivity to AAL and responded weakly to allogeneic stimulators,  as 
expected, because cultures were harvested on day 3, rather than on day 6 when the 
peak of primary MLR occurs. The allogeneic MLR responses were almost obscured 
in the presence of MAb Q5/13. 
Lymphocytes from individual  B  (DR2,  DR5),  primed against lymphoblasts from 
an A-anti-B MLC, behaved like an anti-DR3 PLT. They were reactivated by all the 
MLC-stimulated  blasts  derived  from individual  A  (i.e.,  from the  ABx,  ACx,  ADx, 
and AEx MLC) as well as by PBL from the DR3-positive (A, C, and D) but not from 
the DR3-negative (B and E) donors.  Thus, as proven in this allogeneic PLT system, 
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TABLE | 
Secondary AMLR  (3-d Culture) 
285 
Mono- 
Respnnders  clonal 
(OKT-3  ÷ T cells)  anti-la 
"  added 
Irradiated stimulating cells 
MLC-activated T  [ymphnblasts*  Monncyte-depleted PBL 
Ax  Bx  Cx  Dx  Ex  ABx  ACx  ADx  AEx 
DR3.5  DR2,5  DR3.4  DR 1,3  DR2,2 
A primed to ABx  No  6,320  620  430  5,420  310  450  620  830  540 
Yes  5.840  7811  340  6.210  230  260  580  1,010  860 
A resting T  cel[s:~  No  1,560  1,810  1,940  1.270  960  8,410  4,512  5.710  4,510 
Yes  960  1,21X)  1.660  540  410  3,21X)  2,1110  2.350  1,240 
B primed to ABx  Nn  15,2'.]0  21,710  11,2111  13.841.1  19,4211  1.210  17,80(1  12,210  2,2111 
Yes  6.820  5,4.tX)  6,370  4.550  10,250  340  2,51X)  4.820  1,41X; 
B resting T cells{}  No  4,810  5,710  6,820  3,290  6,540  850  4,850  5,010  320 
Yes  1.240  2,260  2,410  1,820  3,770  680  2.110  1.980  640 
Results  are expressed  as mean cpm of triplicate cultures. 
* MLC-activated T  lymphoblasts: ABx DR3,5 primed to DR2,5; ACx DR3,5 primed to DR3,4; ADx DR3,5 primed 
AEx DR3,5 primed to DR2,2. 
:~ Resting fresh T cells from individual A. 
§ Resting fresh T  cells from individual B. 
to DR 1,3; 
stimulatory  activity,  although  only  lymphoblasts  primed  to  DR2  reactivated  the 
secondary AMLR in the autologous system. When the anti-DR3  PLT was tested in 
the presence of monoclonal anti-Ia antibody,  a  significant  inhibition  of secondary 
responses  was  observed.  Fresh  lymphocytes  from  individual  B  responded  to  all 
allogeneic stimulators in the expected pattern and showed decreased reactivity in the 
presence of anti-Ia antibody. 
Results of three additional experiments confirming the specificity of the memory 
response  to  AAL  are  illustrated  in  Fig.  1.  In  experiment  I,  the  responder  (DR2, 
DRw6)  was  primed against  AL that  had been activated against  DR5  (i.e., against 
stimulator  B  with  the  DR2,  DR5  phenotype).  This  PLT was  reactivated  by AL 
sensitized either to the original stimulator (B)  or to other DR5-positive individuals 
(C, D, and E), but not by AL sensitized to DR7 (F) or DR3 (G). In experiment II, the 
responder (DR2, DR5) was primed to AL that had been alloactivated against  DR3 
(present on stimulator B with the DR2, DR3 phenotype). Secondary responses were 
induced by AL activated against DR3, but not by AL activated against another DR 
antigen such as DRw6. In experiment III, a DR3, DR5 responder was primed to AL 
alloactivated  against  DR4.  Like  in  the  previous  experiments,  restimulation  was 
induced by AL primed to the DR antigen of the original allostimulator (DR4 in this 
case). 
In all three experiments, resting lympocytes displayed a  low 66-h response to AL, 
regardless  of the  DR  specificity  against  which  the  AL  were  alloactivated.  The 
significantly higher 66-h reactivity exhibited by the anti-AL PLT can therefore be 
attributed  to accelerated, memory responses.  In  experiments I  and  II,  the AMLR 
response to autologous phytohemagglutinin (PHA)-activated lymphoblasts was also 
tested.  The  reactivity  displayed  by  anti-AAL-primed  lymphocytes  to  autologous 
PHA-blasts was of the same order of magnitude as that displayed by resting OKT-3  ÷ 
cells. 286  SUCIU-FOCA ET  AL.  BRIEF  DEFINITIVE REPORT 
Irradiated  Stimulating  Lymphoblasts 
A.._.B  x  AC X  ADx  AE x  A...~_F  x  AG x 
A  --'~  --~  --~  A 
anti  anti  anti  anti  anti  anti  A 
25  Dr 2.5  Dr 25  Dr 56  Dr 5.5  Dr 2.7  Dr 23  T-pHA 
":I  ,o  i 
Ex  15 
tutJ 
25 
•  ~  20  ~0 
.fix 15 
,o 
,,'I, t)  5 
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A  A  A  A 
anti  anti  anti  anh  A 
Dr 23  Dr 33  Dr 35  Dr 56  T-PHA 
Responders: 
[] A (Dr 2,6) primed 
to ABx(Dr 2,6 
anti Dr 2,5) 
•  A (Dr 2,6) resting 
T ceils 
Responders: 
I--]A (Dr 2,5) primed 
to ABx(Dr 2,5 
anti Dr 2,3) 
•  A (Dr 2,5) resting 
T Cells 
AB x  AC  x  A  D  x  AE x 
A  A  A  A 
~5  anti  anti  an~i  anh 
Dr34  Dr4,4  0r2,2  Dr  I  3 
I~  ~"-  20 
o  i--q  Responders: 
¢'-  15  I  I  F]A(Dr3,5)  primed 
"$~  DO  anti Dr 3,4) 
'~Q"  BBA (Dr 3,5) resting  ,,xo  5  ~-~  T Cells 
Fro.  t.  Lymphocytes  primed  in  primary  AMLR  to  autologous  alloactivated T  lymphoblasts 
display  secondary  AMLR  responses  only  when  restimulated  with  autologous  T  lymphoblasts 
sensitized  to the same HLA-DR alloantigen as the primary stimulators. 
Discussion 
Human T  lymphocytes seem to have clonally distributed receptors for HLA-D/DR 
antigens as demonstrated by the specificity of the recognition and memory phase of 
the  in  vitro  (MLC)  response  to allogeneic stimulators  (11,  12). The present  study 
suggests that T  lymphoblasts alloactivated against a given HLA-DR antigen express 
idiotype-like receptors, as  they are capable of inducing an  AMLR  response specific 
for the receptor expressed by the AAL. Thus, PLT generated against  AL primed to 
a  certain  allogeneic HLA-DR  are  restimulated  only by AL  sensitized  to  the same 
specificity and not by AL alloactivated against a different HLA-DR. 
Because  T  lymphocytes  may  have  on  their  surface  not  only  antigen-binding 
idiotypic receptors but  also  alloantigens of the stimulator  type, it could be argued 
that  both  the primary  and  the secondary AMLR  were, in  fact,  triggered  by such 
soluble HLA alloantigen(s) coating the outersurface of the MLC blasts. This does not 
seem  to  be the case,  however,  as  allogeneic PBL  from  the sensitizing donor  failed  to 
induce an  accelerated  response  when  used  for testing  the specificity of the secondary 
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On the other hand, because Ia antigens may account for the capacity of B cells and 
monocytes to stimulate in AMLR  (4-6), the question might be raised whether the 
response induced by MLC alloactivated T  cells is caused by their capacity to express 
HLA-D and  DR  antigens  (1-3,  13,  14).  This possibility is unlikely in  view of two 
observations.  First,  AAL  primed  against  HLA-DR  antigens,  different  from  that 
against  which  the  primary  (AAL)  stimulator  was  sensitized,  did  not  trigger  the 
secondary PLT response.  Second, the  specific memory response displayed by such 
PLT was not inhibited by the monoclonal anti-Ia, as would have been expected if the 
response were directed against Ia. 
Autologous stimulation  of primed  lymphocytes that  does not  require specifically 
stimulated  cells,  such  as  non-T cells or  PHA-activated  lymphocytes, has  been  de- 
scribed, however, by other authors (15-17). Although idiotype determinants expressed 
by B lymphocytes or by polyclonally PHA-activated T  cells might also be involved in 
such secondary AMLR, the self-stimulatory capacity of IgM-negative B cells, mono- 
cytes, and null cells (4-6) calls for a  different explanation. This might well reside in 
the possibility that the human AMLC response is primarily specific for the heterolo- 
gous  proteins  adsorbed  to  antigen-presenting  cells  during  rosette  formation  with 
SRBC  (18).  This  phenomenon  had  no  impact  on  our  own  experiments  as  the 
secondary AMLR  response was  specific for the idiotype-like determinant expressed 
by the primary stimulator. 
Finally, the above considerations do not exclude the possibility that recognition of 
self-Ia is part of the process of self-non-self discrimination. In fact, previous studies 
showing that strong anti-allo-Ia reactive T  cell receptors also exhibit weak reactivity 
to self-Ia may indicate that  reactivity to self-Ia, plus additional antigen,  represents 
the true biological reason for the existence of the large repertoire of alloreactive T  cell 
clones (19). 
Summary 
T  cells alloactivated in  5-d MLC with  an  HLA-DR-different stimulator acquire 
the capacity of stimulating the autologous mixed lymphocyte response (AMLR). We 
have demonstrated that activation of AMLR by allosensitized T  cells is determined 
by the expression of the idiotype receptor for the stimulating HLA-DR alloantigen. 
This  has  been  shown  in  experiments  in  which  purified,  OKT-3-positive  T  cell 
suspensions  were first  primed  for 9  d  with  AMLR-activated T  lymphoblasts,  then 
tested in secondary AMLR with autologous lymphoblasts sensitized to various HLA- 
DR  alloantigens.  Accelerated memory responses  were  induced only by autologous 
lymphoblasts that had been sensitized against  the same HLA-DR specificity as the 
primary AMLR stimulators. This response was not inhibited by a mouse monoclonal 
antibody recognizing Ia-like determinants, and was not triggered by human allogeneic 
resting peripheral blood lymphocytes. Thus, recognition of alloactivated T  lympho- 
blasts  in  secondary AMLR  seems  to be specific for the  idiotype-like determinants 
expressed by the autologous stimulators. 
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